Pharmafile Logo

Patient Recruitment in Oncology: A Phase III Melanoma Case Study

Boosting screening & enrollment rates in a global oncology trial

- PMLiVE

This Phase III global clinical trial for patients with either stage IIIB or IV unresectable melanoma involved 118 research sites across 25 countries. For this particular study, the sponsor had never run an oncology study before, so we were commissioned to provide in-country support to help sites overcome patient recruitment challenges.

Download the case study here

This content was provided by Innovative Trials

Company Details

 Latest Content from  Innovative Trials 

Innovative Trials recognised at the PMEA Awards 2023 Gala Dinner

Global patient recruitment Innovative Trials took part of the PMEA Awards gala dinner alongside the best players in the pharmaceutical industry.

Innovative Trials launches the Retention Patch Program

Innovative Trials has unveiled a new partnership with the non-profit Oliver Patch Project to boost retention in pediatric studies.

Innovative Trials at the 2023 Lloyds Bank British Business Excellence Awards

Innovative Trials achievements recognized at the Lloyds Bank British Business Excellence Awards

Innovative Trials has been shortlisted in the PMEA Awards

Innovative Trials finalist in the Support Agency of the Year at the annual PMEA industry awards.

A New Era in Patient Recruitment & Retention

Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention .

Navigator – Revolutionize your patient recruitment and retention

Welcome to the new era in patient recruitment and retention

Innovative Trials partner with Great Ormond Street Hospital Children’s Charity

The patient recruitment company has chosen their UK charity partner for 2022/2023

Patient recruitment company, Innovative Trials, nominated a finalist in prestigious award

UK-based patient recruitment company celebrates an incredible achievement in a national award nomination